Animal Antibacterial Peptide Market - Global Forecast 2026-2032

The animal antibacterial peptide market is rapidly transforming as senior decision-makers address shifting global animal health priorities, regulatory changes, and the drive toward sustainable production. Favored for their innovation potential and role in antimicrobial resistance mitigation, antibacterial peptides now demand focused investment strategies and cross-industry partnerships.

Market Snapshot: Antibacterial Peptide Market Overview

The Animal Antibacterial Peptide Market advanced from USD 4.69 billion in 2025 to USD 5.42 billion in 2026, with forecasts indicating continued robust expansion and a CAGR of 17.68% that will raise the market value to USD 14.68 billion by 2032. Growth is fueled by advances at the intersection of peptide science and intensified efforts in antibiotic stewardship, prompting a recalibration of market priorities. This evolution underscores the role of antibacterial peptides in animal health management, where new forms, delivery systems, and applications present clear opportunities for differentiation. The market serves a broad spectrum of production systems and is essential for executives seeking strategies to respond to sustainability and antimicrobial resistance objectives.

Scope & Segmentation

Product Types: Naturally derived peptides and synthetic peptides each provide distinct advantages in regulatory compliance, product stability, and market perception, shaping portfolio planning.
Peptide Formats: Long, medium, and short chain formats influence formulation choices, manufacturing methods, and the breadth of antimicrobial action achieved in end products.
Applications: Growth promotion, prophylactic applications, therapeutic uses such as vaccination adjuvants, disease prevention, and treatment of infections or dermatological conditions all create layered paths to market entry.
End-User Segments: Aquaculture producers, livestock feed manufacturers (with a distinction between aquafeed and livestock specialties), veterinary clinics, and research institutions each represent distinct adoption drivers and product requirements.
Regional Coverage: The Americas, Europe Middle East & Africa, and Asia-Pacific regions feature unique regulatory conditions, delivery networks, and animal husbandry approaches, each influencing product launch and scaling strategies.
Technological Platforms: Synthesis advancements, innovations in formulation, increasing digital health integration, and cross-species product adaptability are shaping new value propositions and market visibility for peptide-based solutions.

Key Takeaways for Senior Decision-Makers

Accelerating progress in peptide engineering and synthetic biology is positioning antibacterial peptides as a pivotal alternative to traditional antimicrobial options across animal health applications.
The path from laboratory innovation to commercial-scale deployment brings significant characterization, stability, and manufacturing scalability challenges, highlighting the need to align R&D investment with operational realities.
Regional adoption patterns vary: the Americas prioritize integration and regulatory compliance; EMEA has a sharper focus on antimicrobial resistance and rigorous safety; Asia-Pacific's rapid aquaculture growth demands more flexible, broadly adaptable solutions.
End-user diversity across aquaculture, feed manufacturing, veterinary practice, and research means commercial rollout must account for differing adoption criteria, evidence requirements, and sequencing of market entry phases.
Strategic collaborations spanning research, digital technology integration, and distribution contribute to both regulatory efficiency and accelerated go-to-market timelines, reducing barriers while supporting responsible stewardship.

Tariff Impact on Supply Chains & Sourcing

The evolving tariff environment in the United States is shaping both procurement and supply chain management decisions for peptide-based animal health products. Companies are reassessing the relative costs and advantages of importing versus sourcing domestic raw materials in light of shifting tariffs. These changes influence supplier selection, manufacturing site strategies, and have prompted organizations to expand supplier diversification, adopt nearshoring, and integrate vertically where possible to manage tariff risk. Complexities tied to import licensing, customs processes, and existing trade agreements further increase the importance of agile scenario planning to maintain supply chain stability and resilience.

Methodology & Data Sources

This report is based on a rigorous mixed-methods framework, including structured interviews with experts in peptide chemistry, veterinary science, and regulatory policy. Cross-referencing these insights with technical and peer-reviewed literature, as well as official regulatory documentation, provides a comprehensive and evidence-based foundation for identifying market dynamics and barriers to adoption.

Why This Report Matters

Offers actionable guidance for product development, regulatory compliance, and targeted market entry tailored to the animal antibacterial peptide sector.
Clarifies the effects of tariff fluctuations, region-specific regulations, and sourcing complexities, supporting more strategic supply chain and procurement decisions.
Helps prioritize investments, form effective partnerships, and drive operational initiatives that address commercial constraints while advancing stewardship and sustainability in animal health.

Conclusion

Organizational success in the antibacterial peptide space hinges on effectively connecting scientific rigor with scalable business execution. Those able to validate products, navigate regional market variations, and establish strong cross-sector partnerships will secure early advantages as the industry grows in complexity.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Antibacterial Peptide Market, by Product Type

8.1. Naturally Derived Peptide
8.2. Synthetic Peptide
8.2.1. Long Chain
8.2.2. Medium Chain
8.2.3. Short Chain

9. Animal Antibacterial Peptide Market, by Application

9.1. Growth Promotion
9.2. Prophylactic
9.2.1. Disease Prevention
9.2.2. Vaccination Adjuvant
9.3. Therapeutic
9.3.1. Infection Treatment
9.3.2. Skin Disease Treatment

10. Animal Antibacterial Peptide Market, by End User

10.1. Aquaculture Farms
10.2. Feed Manufacturers
10.2.1. Aquafeed
10.2.2. Livestock Feed
10.3. Research Institutes
10.3.1. Academic Institute
10.3.2. Biotech Company
10.4. Veterinary Clinics
10.4.1. Large Animal Practice
10.4.2. Small Animal Practice

11. Animal Antibacterial Peptide Market, by Region

11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific

12. Animal Antibacterial Peptide Market, by Group

12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO

13. Animal Antibacterial Peptide Market, by Country

13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea

14. United States Animal Antibacterial Peptide Market
15. China Animal Antibacterial Peptide Market

16. Competitive Landscape

16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. AB Vista Limited
16.6. AgroBioTek Laboratories LLC
16.7. Animal Medics
16.8. Anitox Corporation
16.9. Biogenesis Bagó S.A.
16.10. Biosynth Ltd
16.11. Boehringer Ingelheim International GmbH
16.12. Cargill, Incorporated
16.13. Dechra Pharmaceuticals PLC
16.14. Eco Animal Health Ltd.
16.15. Elanco Animal Health Incorporated
16.16. Esco Aster Pte. Ltd.
16.17. Genera Inc.
16.18. Huvepharma S.A.
16.19. ImmuCell Corporation
16.20. Kemin Industries, Inc.
16.21. Merck & Co., Inc.
16.22. Neogen Corporation
16.23. Novozymes A/S
16.24. Phibro Animal Health Corporation
16.25. Vetbiochem India Pvt Ltd.
16.26. Vetoquinol S.A.
16.27. Zoetis Inc.
16.28. Zomedica Pharmaceuticals Corp.

List of Figures

FIGURE 1. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY NATURALLY DERIVED PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY NATURALLY DERIVED PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY NATURALLY DERIVED PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LONG CHAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LONG CHAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LONG CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MEDIUM CHAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MEDIUM CHAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY MEDIUM CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SHORT CHAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SHORT CHAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SHORT CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VACCINATION ADJUVANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VACCINATION ADJUVANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VACCINATION ADJUVANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY INFECTION TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY INFECTION TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY INFECTION TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SKIN DISEASE TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SKIN DISEASE TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SKIN DISEASE TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE FARMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE FARMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUACULTURE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUAFEED, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUAFEED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY AQUAFEED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK FEED, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK FEED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LIVESTOCK FEED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ACADEMIC INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ACADEMIC INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY ACADEMIC INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY BIOTECH COMPANY, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY BIOTECH COMPANY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY BIOTECH COMPANY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LARGE ANIMAL PRACTICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LARGE ANIMAL PRACTICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY LARGE ANIMAL PRACTICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SMALL ANIMAL PRACTICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SMALL ANIMAL PRACTICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SMALL ANIMAL PRACTICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 118. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 121. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 123. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 124. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 126. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 127. EUROPE ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 138. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 140. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 141. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 143. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 144. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 146. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 147. AFRICA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 161. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 162. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 164. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 165. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 167. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 168. ASEAN ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 169. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 172. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 174. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 175. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 177. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 178. GCC ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 189. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 192. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 194. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 195. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 197. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 198. BRICS ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 199. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 202. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 204. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 205. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 207. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 208. G7 ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 209. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 211. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 212. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 214. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 215. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 217. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 218. NATO ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)
TABLE 230. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 231. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 232. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY SYNTHETIC PEPTIDE, 2018-2032 (USD MILLION)
TABLE 233. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY PROPHYLACTIC, 2018-2032 (USD MILLION)
TABLE 235. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 236. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY FEED MANUFACTURERS, 2018-2032 (USD MILLION)
TABLE 238. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 239. CHINA ANIMAL ANTIBACTERIAL PEPTIDE MARKET SIZE, BY VETERINARY CLINICS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Animal Antibacterial Peptide market report include:

AB Vista Limited
AgroBioTek Laboratories LLC
Animal Medics
Anitox Corporation
Biogenesis Bagó S.A.
Biosynth Ltd
Boehringer Ingelheim International GmbH
Cargill, Incorporated
Dechra Pharmaceuticals PLC
Eco Animal Health Ltd.
Elanco Animal Health Incorporated
Esco Aster Pte. Ltd.
Genera Inc.
Huvepharma S.A.
ImmuCell Corporation
Kemin Industries, Inc.
Merck & Co., Inc.
Neogen Corporation
Novozymes A/S
Phibro Animal Health Corporation
Vetbiochem India Pvt Ltd.
Vetoquinol S.A.
Zoetis Inc.
Zomedica Pharmaceuticals Corp.

Table Information

Report Attribute	Details
No. of Pages	185
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 5.42 Billion
Forecasted Market Value ( USD ) by 2032	$ 14.68 Billion
Compound Annual Growth Rate	17.6%
Regions Covered	Global
No. of Companies Mentioned	25

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3471EUR$3,939USD£3,022GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3745EUR$4,249USD£3,259GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5075EUR$5,759USD£4,418GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6142EUR$6,969USD£5,346GBP

Market Snapshot: Antibacterial Peptide Market Overview

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact on Supply Chains & Sourcing

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Animal Antibiotics & Antimicrobials Market - Global Forecast 2026-2032

Animal Antibiotics and Antimicrobials - Global Strategic Business Report

Animal Antibiotics and Antimicrobials Global Market Report 2025

Animal Antibiotics and Antimicrobials Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

Animal Antibiotics and Antimicrobials: Market Share, and Growth Analysis by Product Type (Tetracyclines, Penicillins, Macrolides, Sulfonamides), Application, End User, Technology